Image pharmaphorum Editor News AZ's Imfinzi hits second lung cancer trial goal But AZ is anxiously waiting for results of MYSTIC trial Digital Sponsored How to make digital work in medtech Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech. News LuViva scanner could provide alternative to smear test Device is 18 months from US approval News Evotec and Celgene unite to drive forward oncology R&D Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology. Load more results
News AZ's Imfinzi hits second lung cancer trial goal But AZ is anxiously waiting for results of MYSTIC trial
Digital Sponsored How to make digital work in medtech Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech.
News Evotec and Celgene unite to drive forward oncology R&D Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology.
News In brief SOTU remarks, Trump asks Congress to "codify" MFN In a speech at least nominally focused on the economy and affordability, President Trump put surprisingly little emphasis on his drug pricing efforts.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
